Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the appointment of Scott Neils as Interim Chief Financial Officer succeeding Greg Jensen, the Company’s current Vice President, Finance and Chief Financial Officer, effective January 3, 2022.
Latest Fintech Insights: REPAY Announces Acquisition of Payix
“We are excited to announce this well deserved promotion for Scott. His demonstrated ability to oversee the Company’s finance and accounting operations in his current role as the Company’s Controller and his depth of experience in accounting will continue to be a great benefit to Xtant Medical,” said Sean Browne, President and Chief Executive Officer of Xtant Medical. “Additionally, we sincerely thank Greg for his dedication, leadership and lasting impact on the Company during his almost three-year tenure with the Company.”
Browse The Complete News About Fintech : SAWA Crypto Fund Syndicate Protocol is Giving Investors Access to Seed Rounds with Minimum Investment
Mr. Neils has 15 years of experience focused on public accounting and corporate finance and has served as the Company’s Controller since August 2019. In this role, Mr. Neils gained extensive experience managing the Company’s finance and accounting functions. Prior to joining Xtant Medical, Mr. Neils served as Audit Senior Manager at Baker Tilly US, LLP (formerly Baker Tilly Virchow Krause, LLP), an advisory, tax and assurance firm, from November 2015 to August 2019. Prior to that position, Mr. Neils was at Grant Thornton LLP, an accounting and advisory organization, from September 2007 to November 2015, most recently as Audit Manager. Mr. Neils is a Certified Public Accountant. He holds a Bachelor of Science in Business in Accounting and a Master of Accountancy from the Carlson School of Management at the University of Minnesota.
Read More About Fintech News : Brown & Brown, Inc. Announces The Asset Acquisition Of HARCO Insurance Services and HARCO Financial Services
[To share your insights with us, please write to sghosh@martechseries.com]
